How Cannabis Affects Eye Movements Relevant to Driving

Acute THC use slows and impairs eye movement control, while chronic users show lasting deficits in visual scanning.

Manning, Brooke et al.·Addiction biology·2024·Moderate EvidenceSystematic Review
RTHC-05508Systematic ReviewModerate Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Systematic Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Across 20 studies, acute THC consumption increased saccadic latency, reduced accuracy, and impaired inhibitory control. Chronic cannabis users, particularly those who started young, showed enduring oculomotor deficits affecting visual scanning efficiency. Eyelid tremors appeared to be a reliable indicator of cannabis consumption but were distinct from impairment.

Key Numbers

20 studies included (12 acute dosing, 5 chronic use, 3 roadside). Acute THC increased saccadic latency and inaccuracy. Chronic users with early onset showed lasting oculomotor deficits.

How They Did This

Systematic review registered on OSF following PRISMA guidelines. Twenty articles included: 12 acute dosing trials, 5 chronic use cross-sectional studies, and 3 roadside epidemiological studies.

Why This Research Matters

Current roadside cannabis tests detect THC but do not measure actual impairment. Identifying specific eye movement changes could lead to more accurate, impairment-based testing.

The Bigger Picture

As cannabis legalization spreads, the gap between detecting consumption and proving impairment becomes a legal and safety issue. Eye movement testing could bridge this gap.

What This Study Doesn't Tell Us

Heterogeneous study designs and THC doses limit direct comparison. Most acute studies used controlled lab settings that may not reflect real-world driving.

Questions This Raises

  • ?Could an eye-tracking device provide a standardized, objective roadside impairment test for cannabis?
  • ?Do oculomotor deficits in chronic users recover after extended abstinence?

Trust & Context

Key Stat:
Acute THC slows eye movements and impairs inhibitory control; chronic users show lasting deficits
Evidence Grade:
Systematic review with pre-registration and PRISMA reporting, though included studies varied in design and THC dosing.
Study Age:
Published in 2024.
Original Title:
A systematic review of oculomotor deficits associated with acute and chronic cannabis use.
Published In:
Addiction biology, 29(1), e13359 (2024)
Database ID:
RTHC-05508

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Analyzes all available research on a topic using a structured method.

What do these levels mean? →

Frequently Asked Questions

Can eye tests detect cannabis impairment?

THC causes measurable changes in eye movements including slower reactions and reduced accuracy. Eyelid tremors also appear to be a reliable sign of consumption.

Do long-term cannabis users have permanent eye movement problems?

Chronic users, especially those who started young, showed lasting visual scanning deficits, but whether these are fully reversible with abstinence is not yet known.

Read More on RethinkTHC

Cite This Study

RTHC-05508·https://rethinkthc.com/research/RTHC-05508

APA

Manning, Brooke; Downey, Luke A; Narayan, Andrea; Hayley, Amie C. (2024). A systematic review of oculomotor deficits associated with acute and chronic cannabis use.. Addiction biology, 29(1), e13359. https://doi.org/10.1111/adb.13359

MLA

Manning, Brooke, et al. "A systematic review of oculomotor deficits associated with acute and chronic cannabis use.." Addiction biology, 2024. https://doi.org/10.1111/adb.13359

RethinkTHC

RethinkTHC Research Database. "A systematic review of oculomotor deficits associated with a..." RTHC-05508. Retrieved from https://rethinkthc.com/research/manning-2024-a-systematic-review-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.